专业LVEFβ-阻滞剂
β-阻滞剂治疗心肌梗死后性别特异性结局：来自REBOOT试验的见解
By MedXY|2025年10月7日
REBOOT试验揭示了心肌梗死（MI）后β-阻滞剂的性别特异性差异效应，显示在左室射血分数（LVEF）保留的女性中增加了危害，挑战了当前指南的推荐。
MedXY新闻
中文标签LVEF
向 MedXY AI 提问
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.
